Rhodiola Crenulata as an Adjunctive Therapy in COPD
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
We hypothesize that add-on Rhodiola L extract capsule to the regimen of patients with
moderate-to-severe COPD (1) may provide a potential of systemic effects of anti-inflammation
and anti-oxidation for these patients, and these effects (2) may reflect in the improvement
of patients' physiological measurements, quality of life and exercise tolerance.